Literature DB >> 30302720

Oxidative Stress and Inflammation, Key Targets of Atherosclerotic Plaque Progression and Vulnerability: Potential Impact of Physical Activity.

Pauline Mury1,2, Erica N Chirico3, Mathilde Mura1,2, Antoine Millon4,5, Emmanuelle Canet-Soulas4, Vincent Pialoux6,7,8.   

Abstract

Atherosclerosis, a complex cardiovascular disease, is a leading cause of mortality and morbidity worldwide. Oxidative stress and inflammation are both involved in the development of atherosclerotic plaque as they increase the biological processes associated with this pathology, such as endothelial dysfunction and macrophage recruitment and adhesion. Atherosclerotic plaque rupture leading to major ischemic events is the result of vulnerable plaque progression, which is a result of the detrimental effect of oxidative stress and inflammation on risk factors for atherosclerotic plaque rupture, such as intraplaque hemorrhage, neovascularization, and fibrous cap thickness. Thus, both are key targets for primary and secondary interventions. It is well recognized that chronic physical activity attenuates oxidative stress in healthy subjects via the improvement of antioxidant enzyme capacities and inflammation via the enhancement of anti-inflammatory molecules. Moreover, it was recently shown that chronic physical activity could decrease oxidative stress and inflammation in atherosclerotic patients. The aim of this review is to summarize the role of oxidative stress and inflammation in atherosclerosis and the results of therapeutic interventions targeting them in both preclinical and clinical studies. The effects of chronic physical activity on these two key processes are then reviewed in vulnerable atherosclerotic plaques in both coronary and carotid arteries.

Entities:  

Mesh:

Year:  2018        PMID: 30302720     DOI: 10.1007/s40279-018-0996-z

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  208 in total

1.  Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults.

Authors:  Earl S Ford
Journal:  Epidemiology       Date:  2002-09       Impact factor: 4.822

2.  Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity).

Authors:  Paul D Thompson; David Buchner; Ileana L Pina; Gary J Balady; Mark A Williams; Bess H Marcus; Kathy Berra; Steven N Blair; Fernando Costa; Barry Franklin; Gerald F Fletcher; Neil F Gordon; Russell R Pate; Beatriz L Rodriguez; Antronette K Yancey; Nanette K Wenger
Journal:  Circulation       Date:  2003-06-24       Impact factor: 29.690

3.  Absence of age-related increase in central arterial stiffness in physically active women.

Authors:  H Tanaka; C A DeSouza; D R Seals
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-01       Impact factor: 8.311

Review 4.  Microvascular NADPH oxidase in health and disease.

Authors:  Yao Li; Patrick J Pagano
Journal:  Free Radic Biol Med       Date:  2017-03-06       Impact factor: 7.376

5.  Gain and loss of function for glutathione synthesis: impact on advanced atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Andrea Callegari; Yuhua Liu; Collin C White; Alan Chait; Peter Gough; Elaine W Raines; David Cox; Terrance J Kavanagh; Michael E Rosenfeld
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

6.  High-density lipoprotein metabolism in runners and sedentary men.

Authors:  P N Herbert; D N Bernier; E M Cullinane; L Edelstein; M A Kantor; P D Thompson
Journal:  JAMA       Date:  1984 Aug 24-31       Impact factor: 56.272

Review 7.  Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies.

Authors:  Carlos Silvestre-Roig; Menno P de Winther; Christian Weber; Mat J Daemen; Esther Lutgens; Oliver Soehnlein
Journal:  Circ Res       Date:  2014-01-03       Impact factor: 17.367

8.  Correlation between the levels of circulating adhesion molecules and atherosclerosis in hypertensive type-2 diabetic patients.

Authors:  Alberto Francisco Rubio-Guerra; Hilda Vargas-Robles; Alberto Maceda Serrano; German Vargas-Ayala; Leticia Rodriguez-Lopez; Bruno Alfonso Escalante-Acosta
Journal:  Clin Exp Hypertens       Date:  2010       Impact factor: 1.749

9.  Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells.

Authors:  Aleksandr E Vendrov; Zeenat S Hakim; Nageswara R Madamanchi; Mauricio Rojas; Chaitanya Madamanchi; Marschall S Runge
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-09-06       Impact factor: 8.311

10.  Associations between Fatness, Fitness, IGF and IMT among Obese Korean Male Adolescents.

Authors:  Eun Sung Kim; Ji-Hye Park; Mi Kyung Lee; Dong Hoon Lee; Eun Seok Kang; Hyun Chul Lee; Yoonsuk Jekal; Justin Y Jeon
Journal:  Diabetes Metab J       Date:  2011-12-26       Impact factor: 5.376

View more
  18 in total

1.  Identification of pathways and key genes in male late-stage carotid atherosclerosis using bioinformatics analysis.

Authors:  Di Zhang; Xin Li; Bei Jing; Huimei Shi; Shiquan Chang; Zhenni Chen; Yachun Zheng; Yuwei Pan; Guoqiang Qian; Guoping Zhao
Journal:  Exp Ther Med       Date:  2022-05-20       Impact factor: 2.751

2.  Histopathological correlation of near infrared autofluorescence in human cadaver coronary arteries.

Authors:  Mie Kunio; Joseph A Gardecki; Kohei Watanabe; Kensuke Nishimiya; Sarika Verma; Farouc A Jaffer; Guillermo J Tearney
Journal:  Atherosclerosis       Date:  2022-01-29       Impact factor: 6.847

3.  Hypertension is associated with increased post-exercise albuminuria, which may be attenuated by an active lifestyle.

Authors:  Ayelet Grupper; Michal Ehrenwald; Doron Schwartz; Shlomo Berliner; Moshe Shashar; Roni Baruch; Idit F Schwartz; Ori Rogowski; David Zeltser; Itzhak Shapira; Shani Shenhar-Tsarfaty
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-07-08       Impact factor: 3.738

Review 4.  Chinese Herbal Medicines and Active Metabolites: Potential Antioxidant Treatments for Atherosclerosis.

Authors:  Luxia Song; Jie Zhang; Runmin Lai; Qiuyi Li; Jianqing Ju; Hao Xu
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

5.  Combined Exercise Training Performed by Elderly Women Reduces Redox Indexes and Proinflammatory Cytokines Related to Atherogenesis.

Authors:  André L L Bachi; Marcelo P Barros; Rodolfo P Vieira; Gislene A Rocha; Paula B M de Andrade; Angélica B Victorino; Luiz R Ramos; Claudia F Gravina; José D Lopes; Mauro Vaisberg; Raul C Maranhão
Journal:  Oxid Med Cell Longev       Date:  2019-08-05       Impact factor: 6.543

6.  Deficiency of Adipocyte IKKβ Affects Atherosclerotic Plaque Vulnerability in Obese LDLR Deficient Mice.

Authors:  Weiwei Lu; Se-Hyung Park; Zhaojie Meng; Fang Wang; Changcheng Zhou
Journal:  J Am Heart Assoc       Date:  2019-06-15       Impact factor: 5.501

Review 7.  The Biochemical Markers Associated with the Occurrence of Coronary Spasm.

Authors:  Liang Li; Yong-Ping Jin; Shu-Dong Xia; Chao Feng
Journal:  Biomed Res Int       Date:  2019-09-17       Impact factor: 3.411

8.  The effect of COVID-19 lockdown on lifestyle and mood in Croatian general population: a cross-sectional study.

Authors:  Zoran Đogaš; Linda Lušić Kalcina; Ivana Pavlinac Dodig; Sijana Demirović; Katarina Madirazza; Maja Valić; Renata Pecotić
Journal:  Croat Med J       Date:  2020-08-31       Impact factor: 1.351

9.  Clinical Significance of Serum Kallistatin and ENOX1 Levels in Patients with Coronary Heart Disease.

Authors:  Rui Zhang; Zhenjun Ji; Junyan Cai; Yongjun Li; Genshan Ma
Journal:  Med Princ Pract       Date:  2020-07-24       Impact factor: 1.927

10.  COVID-19 pandemic: the effects of quarantine on cardiovascular risk.

Authors:  Anna Vittoria Mattioli; Matteo Ballerini Puviani; Milena Nasi; Alberto Farinetti
Journal:  Eur J Clin Nutr       Date:  2020-05-05       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.